Stay updated on Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.

Latest updates to the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record describes a completed Phase 2 study of letetresgene autoleucel for advanced myxoid/round cell liposarcoma, with trial design, participant criteria, study locations, and measured outcomes. It also provides study documents and information about sharing participant-level data.SummaryDifference63%

- Check18 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record content and showing only a minimal header/footer.SummaryDifference20%

Stay in the know with updates to Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Letetresgene AutoLeucel in Myxoid/Round Cell Liposarcoma Clinical Trial page.